Goddard Glenn 4
4 · Intellia Therapeutics, Inc. · Filed Sep 9, 2021
Insider Transaction Report
Form 4
Goddard Glenn
EVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-09-07−3,482→ 12,451 totalExercise: $14.58Exp: 2028-12-17→ Common Stock (3,482 underlying) - Exercise/Conversion
Common Stock
2021-09-07$14.58/sh+3,482$50,768→ 3,482 total - Sale
Common Stock
2021-09-07$180.12/sh−3,482$627,178→ 0 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.00 to $180.50, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 7, 2021 at each separate price.
- [F3]The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 11,833 shares as of September 7, 2021.